📈 stocks · US

JNJ

stocks · US
stocks US ISIN US4781601046
Overall assessment · Trend now + news, 30 days ?
▲ Strongly bullish strong Confidence 64 % ?
News situation · 12 items / 30 D
▲ Bullish strong 64 %
4.2 Impact / 10
By source type
News 12

No official disclosure in this window — everything below is reporting about JNJ, not from it.

News, 30 days
Bullish
Signal history

Both worlds over time

Technical and news signals of the last 30 days on one timeline.

Bullish ▲Bearish ▼08.09. · News signal · Impact 6/1009.09. · News signal · Impact 3/1009.09. · News signal · Impact 7/1009.09. · News signal · Impact 7/1010.09. · News signal · Impact 2/1010.09. · News signal · Impact 2/1011.09. · News signal · Impact 8/1011.09. · News signal · Impact 6/1013.09. · News signal · Impact 6/1013.09. · News signal · Impact 2/1013.09. · News signal · Impact 1/1014.09. · News signal · Impact 3/1015.09. · News signal · Impact 6/1016.09. · News signal · Impact 0/10
30 days ago today
Technical signal News signal Size = strength
News, 30 days

What is being reported about JNJ

Asset Snapshot

📝 Overview Generated automatically?

JNJ has been the subject of 15 signals across 15 articles in the last 365 days. Sentiment skews Bullish (60%).

Breakdown: 9 bullish, 0 bearish, 6 neutral. AI confidence averages 59% across all signals.

Most-cited catalysts: J&J announces new strategic initiative (1×), 64th consecutive annual dividend increase (1×), Management target of double-digit growth by the end of the decade (1×). Most-cited risk factors: Uncertainty around the specifics and market reception of the new bet (1×), Broader macro headwinds could overshadow the company's internal moves (1×), Stelara biosimilar revenue erosion of 59.7% (1×).

Keep exploring

Related assets

Same category or comparable signal picture — each card opens the full cockpit.